Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 09/05/2011
PIL Epilim syrup

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 03/11/2010 and displayed until 09/05/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 21/05/2009 and displayed until 03/11/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/04/2008 and displayed until 21/05/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 10/01/2008 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 11/09/2007 and displayed until 10/01/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to side-effects
  • Change to drug interactions
Updated on 04/08/2006 and displayed until 11/09/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/04/2006 and displayed until 04/08/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 21/07/2004 and displayed until 28/04/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/07/2004 and displayed until 21/07/2004
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Pending awaiting re-submission
Updated on 20/07/2004 and displayed until 20/07/2004
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 15/10/2002 and displayed until 20/07/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  sodium valproate